FIBRIPHEN 5
Description
Thrombin reagent proposed for the quantitative determination of fibrinogen in human citrated plasma using a clotting method (Clauss method).
Intended use
-
Measurement of fibrinogen in plasma.
-
Detection of low fibrinogen concentrations.
-
Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation
-
Risk factor for cardiovascular disease and thrombosis
-
Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis).
-
Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.